NCT04681040View on ClinicalTrials.gov

Risk Stratification of COVID-19 Using Urine Biomarkers

Active, not recruitingOBSERVATIONAL
Enrollment

964

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

February 14, 2024

Study Completion Date

March 25, 2024

Conditions
Covid19UrineBiomarkerAcute Respiratory Failure With Hypoxia
Trial Locations (7)

21215

MD Mount Sinai, Baltimore

16208655

National Center Global Health and Medicine, Shinjuku

Unknown

Hospital das Clinicas Ribeirao Preto, Ribeirão Preto

Danish National Biobank, Copenhagen

Unilab Group, Manila

247-8533

Shonan General Hospital, Kamakura

400-8506

Yamanashi Prefectural Central Hospital, Kofu

All Listed Sponsors
lead

National Center for Global Health and Medicine, Japan

OTHER_GOV